Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
UNII: | 2Y3T5IF01Z |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Carcinoma, Squamous Cell | 3 | D002294 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
Carcinoma, Squamous Cell | 3 | D002294 | ClinicalTrials |
Carcinoma, Merkel Cell | 2 | D015266 | ClinicalTrials |
Neuroendocrine Tumors | 2 | D018358 | ClinicalTrials |
Neoplasms | 2 | D009369 | ClinicalTrials |
Glioblastoma | 2 | D005909 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Neoplasms | 2 | D009369 | ClinicalTrials |
Triple Negative Breast Neoplasms | 2 | D064726 | ClinicalTrials |
Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
Malignant Carcinoid Syndrome | 2 | D008303 | ClinicalTrials |
Sarcoma | 2 | D012509 | ClinicalTrials |
Esophageal Neoplasms | 2 | D004938 | ClinicalTrials |
Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
Sarcoma | 2 | D012509 | ClinicalTrials |
Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL4298037 |
FDA SRS | 2Y3T5IF01Z |